Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 11, 2013

Endocyte, Genmab and Gentium

Phase II
Genmab positive on ofatumumab . . . read more

Endocyte to continue NSCLC study . . . read more

Filings
COMP gives positive opinion for Gentium’s Defibrotide . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters